(Q40245246)

English

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

scientific article published on 22 September 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Henry L Y Chan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Scott Fung

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Wan-Long Chuang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Chi-Yi Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Hyung Joon Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Aric Josun Hui

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Harry L A Janssen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Abhijit Chowdhury

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Tak Yin Owen Tsang

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Rajiv Mehta

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Edward Gane

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

John F Flaherty

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Benedetta Massetto

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Anuj Gaggar

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Kathryn M Kitrinos

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Lanjia Lin

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

G Mani Subramanian

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

John G McHutchison

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Young-Suk Lim

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Subrat K Acharya

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Kosh Agarwal

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

GS-US-320-0110 Investigators

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

22 September 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

The lancet. Gastroenterology & hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

185-195

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

AASLD guidelines for treatment of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism for effective lymphoid cell and tissue loading following oral administration of nucleotide prodrug GS-7340.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of efficient hepatic delivery by tenofovir alafenamide (GS-7340) for hepatitis B virus therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naïve HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Association Between Chronic Hepatitis B Virus Infection and Risk of Osteoporosis: A Nationwide Population-Based Study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of retinol-binding protein and β2-microglobulin determination in urine for the early detection of tubular proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2468-1253(16)30024-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40245246&oldid=1590450566"